Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Chronic cerebral hypoperfusion has been suggested to contribute to the progression of dementia. Inflammation and white matter lesion (WML) are involved in the pathologic process. This study investigated whether huperzine A, a natural acetylcholinesterase (AChE) inhibitor, has beneficial effects on long‐lasting inflammation as well as cognitive impairment in a rat model of cerebral hypoperfusion and how it plays these roles. Chronic cerebral hypoperfusion was induced by occlusion of bilateral common carotid arteries (two‐vessel occlusion; 2VO). Huperzine A was initially given 150 min after 2VO and daily for 3, 7, 14, and 28 days. Learning and memory dysfunction as tested by Morris water maze performance was observed in 2VO‐operated rats and was significantly improved by huperzine A treatment. WML and activation staining of immune cells were evaluated by Klüver‐Barrera (KB) and immunohistochemistry, respectively. Myelin damage and increased immunostains were found in optic tract at all indicated days. Huperzine A treatment significantly ameliorated all these phenomena. Moreover, huperzine A also suppressed overexpression of the inflammatory factor tumor necrosis factor‐α (TNF‐α) and overphosphorylation of JNK and p38 mitogen‐activated protein kinases (MAPKs) in a cell model of chronic hypoxia. Preincubation with mecamylamine (MEC), a nicotinic acetylcholine receptor (nAChR) antagonist, for 30 min before hypoxia notably reversed the effects of huperzine A on TNF‐α production and MAPKs phosphorylation. In conclusion, delayed and chronic administration of huperzine A could protect against 2VO‐induced cognitive impairment, which might be related to its beneficial effects on WML, and the nAChR‐dependent cholinergic anti‐inflammation pathway plays an important role. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Subcortical ischaemic vascular dementia
Román, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L., & Chui, H. C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00190-4 · Cited by 1,067
The cholinergic anti-inflammatory pathway
Pavlov, V. A., & Tracey, K. J. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.03.015 · Cited by 622
White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion
Shibata, M., Ohtani, R., Ihara, M., & Tomimoto, H. (2004) · Stroke · doi:10.1161/01.str.0000143725.19053.60 · Cited by 583 · cited 2×
“After chronic cerebral hypoperfusion, microglia and astrocytes are markedly activated (Shibata et al., 2004; SchmidtKastner et al., 2005), which has been thought to be the central phenomenon in chronic inflammation (Teeling and Perry, 2009).”
BackgroundResultSchmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M., & Fazekas, F. (2005) · Annals of Neurology · doi:10.1002/ana.20630 · Cited by 408
Tabet, N. (2006) · Age and Ageing · doi:10.1093/ageing/afl027 · Cited by 285 · cited 1×
“At the turn of this century, AChE inhibitors attracted more attention in clinical use for dementia along with the emergence of the ‘‘cholinergic antiinflammation pathway’’ hypothesis (Pavlov and Tracey, 2005; Tabet, 2006; Walker and Lue, 2007).”
BackgroundAxonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat
Wakita, H., Tomimoto, H., Akiguchi, I., Matsuo, A., Lin, J.-X., Ihara, M., & McGeer, P.-L. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03223-1 · Cited by 197
Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors
Erkinjuntti, T., Román, G., & Gauthier, S. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.018 · Cited by 82
Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Walker, D., & Lue, L.-F. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793667 · Cited by 66
Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia ischemia
Wang, L. S., Zhou, J., Shao, X. M., & Tang, X. C. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02977-3 · Cited by 65 · cited 2×
“These concentrations were shown to be consistently effective in our previous studies (Wang et al., 2002; Wang and Tang, 2007).”
ResultWebster, N. J., Green, K. N., Peers, C., & Vaughan, P. F. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01236.x · Cited by 56 · cited 3×
“5% O2, 5% CO2, balanced with N2 at 378C (Webster et al., 2002; Deng et al., 2008) 12 hr after cultivation.”
MethodInfluential
Cited by
The Pathobiology of Vascular Dementia
Iadecola, C. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.008 · Cited by 1,857
Models and mechanisms of vascular dementia
Venkat, P., Chopp, M., & Chen, J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.006 · Cited by 341
Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
Ebrahimi, A., & Schluesener, H. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.006 · Cited by 270
Experimental models of vascular dementia and vascular cognitive impairment: a systematic review
Jiwa, N. S., Garrard, P., & Hainsworth, A. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06958.x · Cited by 254
Zeng, J., Bao, T., Yang, K., Zhu, X., Wang, S., Xiang, W., Ge, A., Zeng, L., & Ge, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047550 · Cited by 175
Metadata
- Authors
- Wang, J., Zhang, H. Y., & Tang, X. C.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2009-09-30
- Volume
- 88
- Issue
- 4
- Pages
- 807-815
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2099268203
- Cited by
- 95
- References
- 12
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.